Cargando…

SARS-CoV-2 mRNA vaccination elicits broad and potent Fc effector functions to VOCs in vulnerable populations

SARS-CoV-2 variants have continuously emerged even as highly effective vaccines have been widely deployed. Reduced neutralization observed against variants of concern (VOC) raises the question as to whether other antiviral antibody activities are similarly compromised, or if they might compensate fo...

Descripción completa

Detalles Bibliográficos
Autores principales:	Hederman, Andrew P., Natarajan, Harini, Wiener, Joshua A., Wright, Peter F., Bloch, Evan M., Tobian, Aaron A.R., Redd, Andrew D., Blankson, Joel N., Rottenstreich, Amihai, Zarbiv, Gila, Wolf, Dana, Goetghebuer, Tessa, Marchant, Arnaud, Ackerman, Margaret E.
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Cold Spring Harbor Laboratory 2022
Materias:	Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9516864/ https://www.ncbi.nlm.nih.gov/pubmed/36172122 http://dx.doi.org/10.1101/2022.09.15.22280000

Ejemplares similares

SARS-CoV-2 vaccination elicits broad and potent antibody effector functions to variants of concern in vulnerable populations
por: Hederman, Andrew P., et al.
Publicado: (2023)

Boosting of Cross-Reactive Antibodies to Endemic Coronaviruses by SARS-CoV-2 Infection but not Vaccination with Stabilized Spike
por: Crowley, Andrew R., et al.
Publicado: (2021)

Boosting of cross-reactive antibodies to endemic coronaviruses by SARS-CoV-2 infection but not vaccination with stabilized spike
por: Crowley, Andrew R, et al.
Publicado: (2022)

Rapid antigen detection testing for universal screening for severe acute respiratory syndrome coronavirus 2 in women admitted for delivery
por: Rottenstreich, Amihai, et al.
Publicado: (2021)

What is the optinal timing of maternal SARS-CoV-2 mRNA immunization to maximize transplacental antibody transfer?
por: Rottenstreich, Amihai, et al.
Publicado: (2022)

Timing of SARS-CoV-2 vaccination during the third trimester of pregnancy and transplacental antibody transfer: a prospective cohort study
por: Rottenstreich, Amihai, et al.
Publicado: (2022)

Incorporating the Cluster A and V1V2 Targets into a Minimal Structural Unit of the HIV-1 Envelope to Elicit a Cross-Clade Response with Potent Fc-Effector Functions
por: Sherburn, Rebekah, et al.
Publicado: (2021)

Decoding human-macaque interspecies differences in Fc-effector functions: The structural basis for CD16-dependent effector function in Rhesus macaques
por: Tolbert, William D., et al.
Publicado: (2022)

HIV-specific Fc effector function early in infection predicts the development of broadly neutralizing antibodies
por: Richardson, Simone I., et al.
Publicado: (2018)

Antibody Attributes that Predict the Neutralization and Effector Function of Polyclonal Responses to SARS-CoV-2
por: Natarajan, Harini, et al.
Publicado: (2021)

Engineered ACE2-Fc counters murine lethal SARS-CoV-2 infection through direct neutralization and Fc-effector activities
por: Chen, Yaozong, et al.
Publicado: (2021)

Engineered ACE2-Fc counters murine lethal SARS-CoV-2 infection through direct neutralization and Fc-effector activities
por: Chen, Yaozong, et al.
Publicado: (2022)

Younger Children Develop Higher Effector Antibody Responses to SARS-CoV-2 Infection
por: Tomasi, Lisa, et al.
Publicado: (2022)

Antibody attributes that predict the neutralization and effector function of polyclonal responses to SARS-CoV-2
por: Natarajan, Harini, et al.
Publicado: (2022)

286 Genetic, laboratory and clinical factors associated with low-dose aspirin failure in the prevention of preeclampsia
por: Rottenstreich, Amihai, et al.
Publicado: (2023)

Vector induced skewing of antibody Fc-effector functions
por: Chung, A, et al.
Publicado: (2012)

Multiplexed Fc array for evaluation of antigen-specific antibody effector profiles
por: Brown, Eric P., et al.
Publicado: (2017)

Optimization and qualification of an Fc Array assay for assessments of antibodies against HIV-1/SIV
por: Brown, Eric P., et al.
Publicado: (2018)

Sesquiterpene volatile organic compounds (VOCs) are markers of elicitation by sulfated laminarine in grapevine
por: Chalal, Malik, et al.
Publicado: (2015)

Heterologous versus homologous boosting elicits qualitatively distinct, BA.5–cross-reactive T cells in transplant recipients
por: Thompson, Elizabeth A., et al.
Publicado: (2023)

Fc-Engineered Antibodies with Enhanced Fc-Effector Function for the Treatment of B-Cell Malignancies
por: van der Horst, Hilma J., et al.
Publicado: (2020)

mRNA-1273 and BNT162b2 COVID-19 vaccines elicit antibodies with differences in Fc-mediated effector functions
por: Kaplonek, Paulina, et al.
Publicado: (2022)

Severe Infections in HIV-Exposed Uninfected Infants Born in a European Country
por: Adler, Catherine, et al.
Publicado: (2015)

IgG3 enhances neutralization potency and Fc effector function of an HIV V2-specific broadly neutralizing antibody
por: Richardson, Simone I., et al.
Publicado: (2019)

Fc Effector Function Contributes to the Activity of Human Anti-CTLA-4 Antibodies
por: Arce Vargas, Frederick, et al.
Publicado: (2018)

Antigen-dependent modulation of immune responses to antigen-Fc fusion proteins by Fc-effector functions
por: Richel, Elie, et al.
Publicado: (2023)

Structure and Fc-Effector Function of Rhesusized Variants of Human Anti-HIV-1 IgG1s
por: Tolbert, William D., et al.
Publicado: (2022)

A single dose of the SARS-CoV-2 vaccine BNT162b2 elicits Fc-mediated antibody effector functions and T cell responses
por: Tauzin, Alexandra, et al.
Publicado: (2021)

Evidence of variable human Fcγ receptor-Fc affinities across differentially-complexed IgG
por: Crowley, Andrew R., et al.
Publicado: (2023)

Polymeric human Fc-fusion proteins with modified effector functions
por: Mekhaiel, David N. A., et al.
Publicado: (2011)

IgG Fc engineering to modulate antibody effector functions
por: Wang, Xinhua, et al.
Publicado: (2017)

Asymmetric Fc Engineering for Bispecific Antibodies with Reduced Effector Function
por: Escobar-Cabrera, Eric, et al.
Publicado: (2017)

Engineered Fc-glycosylation switch to eliminate antibody effector function
por: Zhou, Qun, et al.
Publicado: (2020)

Fc-engineered antibodies with immune effector functions completely abolished
por: Wilkinson, Ian, et al.
Publicado: (2021)

SARS-CoV-2 antibody signatures robustly predict diverse antiviral functions relevant for convalescent plasma therapy
por: Natarajan, Harini, et al.
Publicado: (2020)

Chemotherapy-based gonadotoxicity risk evaluation as a predictor of reproductive outcomes in post-pubertal patients following ovarian tissue cryopreservation
por: Karavani, Gilad, et al.
Publicado: (2021)

Fragranced Products and VOCs
por: Singal, Madhuri, et al.
Publicado: (2011)

Serum IgA Fc effector functions in infectious disease and cancer
por: Davis, Samantha K, et al.
Publicado: (2020)

Fc-Engineering for Modulated Effector Functions—Improving Antibodies for Cancer Treatment
por: Liu, Rena, et al.
Publicado: (2020)

HIV-1 Vpu restricts Fc-mediated effector functions in vivo
por: Prévost, Jérémie, et al.
Publicado: (2022)

Cannot write session to /tmp/vufind_sessions/sess_ih526bbukbm5u30ak86214p77f